Moreover, by examining clinical data, we found that the expression of four genes, GPR137, NDEL1, DYNC1H1, and TUBA1A, differed significantly between tumor tissues and normal tissues, and their expression levels were significantly associated with poor prognosis of ovarian cancer patients. This evidence concerns the gene DYNC1H1 and ovarian carcinoma.